18953434 | Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer. | Neoplasia | 2008 Nov | Gorringe KL | - |
17289567 | CHD5 is a tumor suppressor at human 1p36. | Cell | 2007 Feb 9 | Bagchi A | - |
19840376 | CHD5 is down-regulated through promoter hypermethylation in gastric cancer. | J Biomed Sci | 2009 Oct 19 | Wang X | doi: 10.1186/1423-0127-16-95. |
22186629 | CHD5, a tumor suppressor that is epigenetically silenced in lung cancer. | Lung Cancer | 2012 Jun | Zhao R | doi: 10.1016/j.lungcan.2011.11.019 |
24923445 | The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping. | J Biol Chem | 2014 Jul 25 | Quan J | - |
18698156 | Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer. | Epigenetics | 2008 Jul-Aug | Mulero-Navarro S | - |
23948251 | CHD5 is required for neurogenesis and has a dual role in facilitating gene expression and polycomb gene repression. | Dev Cell | 2013 Aug 12 | Egan CM | doi: 10.1016/j.devcel.2013.07.008. |
22910690 | Analysis of common variations in tumor-suppressor genes on chr1p36 among Caucasian women with endometriosis. | Gynecol Oncol | 2012 Nov | Falconer H | doi: 10.1016/j.ygyno.2012.08.013 |
23707602 | Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma. | J Clin Neurosci | 2013 Jul | Wang L | doi: 10.1016/j.jocn.2012.07.021 |
24243398 | Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages. | Cancer | 2014 Jan 15 | Fatemi M | doi: 10.1002/cncr.28316 |
21636313 | The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma. | Oral Oncol | 2011 Jul | Wang J | doi: 10.1016/j.oraloncology.2011.05.003 |
25247294 | The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1. | PLoS One | 2014 Sep 23 | Quan J | doi: 10.1371/journal.pone.0108066 |
18413720 | The quest for the 1p36 tumor suppressor. | Cancer Res | 2008 Apr 15 | Bagchi A | doi: 10.1158/0008-5472.CAN-07-2095. |
18577749 | CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. | J Natl Cancer Inst | 2008 Jul 2 | Fujita T | doi: 10.1093/jnci/djn176 |
28400267 | CHD5 is a potential tumor suppressor in non small cell lung cancer (NSCLC). | Gene | 2017 Jun 30 | Baykara O | doi: 10.1016/j.gene.2017.04.010 |
26943038 | The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation. | Oncotarget | 2016 Apr 19 | Du Z | doi: 10.18632/oncotarget.7822. |
22569290 | Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer. | Breast Cancer Res | 2012 May 8 | Wu X | - |
21860208 | CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer. | Gynecol Obstet Invest | 2011 | Wong RR | doi: 10.1159/000323883 |
26753653 | Influence of colorectal cancer tumor suppressor gene CHD5 methylation on its clinical and pathological characteristics. | J Biol Regul Homeost Agents | 2015 Oct-Dec | Liu JB | - |
24276239 | Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. | Oncogene | 2014 Nov 20 | Hall WA | doi: 10.1038/onc.2013.488 |